Skip navigation
  • Home
  • Browse
    • Communities
      & Collections
    • Browse Items by:
    • Publication Date
    • Author
    • Title
    • Subject
    • Department
  • Sign on to:
    • My MacSphere
    • Receive email
      updates
    • Edit Profile


McMaster University Home Page
  1. MacSphere

Browsing by Author Bain, T

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
Showing results 1 to 20 of 87  next >
Publication DateTitleAuthor(s)
Jul-2024Citizen brief: Developing a Type 1 diabetes screening program in CanadaWilson, MG; Scallan, Eilish; Hayeems, R; Bain, T; Velez, CM
Jan-2021COVID-19 living evidence profile #1 (version 1.2): What is known about anticipated COVID-19 vaccine roll-out elements?Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN
Feb-2021COVID-19 living evidence profile #1 (version 1.3): What is known about anticipated COVID-19 vaccine roll-out elements?Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN
Feb-2021COVID-19 living evidence profile #1 (version 1.4): What is known about anticipated COVID-19 vaccine roll-out elements?Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN
Mar-2021COVID-19 living evidence profile #1 (version 1.5): What is known about anticipated COVID-19 vaccine roll-out elements?Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Sharma, K; Whitelaw, S; Lavis, JN
Apr-2021COVID-19 living evidence profile #1 (version 1.6): What is known about anticipated COVID-19 vaccine roll-out elements?Bhuiya, AR; Bain, T; Wang, Q; Al-Khateeb, S; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Drakos, A; Rintjema, J; Sharma, K; Santesso, N; Lavis, JN; Wilson, MG
May-2021COVID-19 living evidence profile #1 (version 1.7): What is known about anticipated COVID-19 vaccine roll-out elements?Bhuiya, AR; Bain, T; Wang, Q; Al-Khateeb, S; DeMaio, P; Ahmad, A; Drakos, A; Rintjema, J; Sharma, K; Matthews, M; Gauvin, François-Pierre; Lavis, JN; Wilson, MG
Mar-2021COVID-19 living evidence profile #2 (version 2.2): What is known about preventing and managing COVID-19, outbreaks of COVID-19, and about supporting renewal in long-term care homes?Waddell, K; DeMaio, P; Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Alam, S; Sharma, K; Whitelaw, S; Gauvin, François-Pierre; Lavis, JN
Apr-2021COVID-19 living evidence profile #2 (version 2.3): What is known about preventing and managing COVID-19, outbreaks of COVID-19, and about supporting renewal in long-term care homes?Waddell, K; DeMaio, P; Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Alam, S; Sharma, K; Whitelaw, S; Gauvin, François-Pierre; Lavis, JN
Jul-2021COVID-19 living evidence profile #2 (version 2.4): What is known about preventing and managing COVID-19, outbreaks of COVID-19, and about supporting renewal in long-term care homes?Waddell, K; DeMaio, P; Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Alam, S; Sharma, K; Whitelaw, S; Gauvin, François-Pierre; Lavis, JN
Oct-2021COVID-19 living evidence profile #2 (version 2.5): What is known about supporting renewal in long-term care homes?Waddell, K; Wilson, MG; Bain, T; Bhuiya, AR; Al-Khateeb, S; Lavis, JN
May-2021COVID-19 living evidence profile #3 (version 3.1): What is known about how schools (K-12) and postsecondary institutions (colleges and universities) adjust COVID-19 transmission-mitigation measures as infection rates change and vaccination rates increase?Bain, T; Bhuiya, AR; Al-Khateeb, S; Wang, Q; Mansilla, C; Rintjema, J; DeMaio, P; Alam, S; Gauvin, François-Pierre; Santesso, N; Lavis, JN; Wilson, MG
Jun-2021COVID-19 living evidence profile #3 (version 3.2): What is known about how schools (K-12) and postsecondary institutions (colleges and universities) adjust COVID-19 transmission-mitigation measures as infection rates change and vaccination rates increase?Bain, T; Bhuiya, AR; Al-Khateeb, S; Wang, Q; Mansilla, C; DeMaio, P; Rintjema, J; Abeer, A; Gauvin, François-Pierre; Matthews, M; Lavis, JN; Wilson, MG
Sep-2021COVID-19 living evidence profile #3 (version 3.3): What is known about how schools (K-12) and post-secondary institutions (colleges and universities) adjust COVID-19 transmission-mitigation measures as infection rates change and vaccination rates increase?Bain, T; Bhuiya, AR; Al-Khateeb, S; Wang, Q; Mansilla, C; Rintjema, J; DeMaio, P; Matthews, M; Lavis, JN; Wilson, MG
May-2021COVID-19 living evidence profile #4 (version 4.1): What went well and what could have gone better in the COVID-19 response in Canada, as well as what will need to go well in future given any available foresight work being conducted?Waddell, K; Wilson, MG; Bain, T; Bhuiya, AR; Al-Khateeb, S; Sharma, K; DeMaio, P; Lavis, JN
Nov-2020COVID-19 rapid evidence profile #23: What is known about anticipated COVID-19 vaccine-delivery program elements, and whether and how federated states are harmonizing these elements across constituent units of federations?Bhuiya, AR; Wilson, MG; Moat, KA; Gauvin, François-Pierre; Wang, Q; Whitelaw, S; Alam, S; Sharma, K; Ahmad, A; Drakos, A; Dren, N; Bain, T; Lavis, JN
Jan-2021COVID-19 rapid evidence profile #25: What do we know from both research and jurisdictional scans about prioritizing vaccination of asymptomatic residents in a long-term care home with an outbreak?Wang, Q; Wilson, MG; Alam, S; Ahmad, A; Bain, T; Bhuiya, AR; Drakos, A; Sharma, K; Whitelaw, S; Bain, T; Lavis, JN
Mar-2021COVID-19 rapid evidence profile #26: When and in what order can COVID-19-related public-health measures be lifted (or stringency be reduced) as vaccination rates and seasonal temperatures increase?Wilson, MG; Bain, T; Wang, Q; Al-Khateeb, S; Bhuiya, AR; Alam, S; DeMaio, P; Gauvin, François-Pierre; Ahmad, A; Sharma, K; Whitelaw, S; Lavis, JN
Jan-2022COVID-19 rapid evidence profile #27: What measures and approaches can protect the most vulnerable in hospitals when outbreaks of Omicron in hospital are becoming more common?Wilson, MG; Bhuiya, AR; Bain, T; Al-Khateeb, S; Mansilla, C; Mehta, V; Sood, T; Soueidan, S; Rintjema, J; Waddell, K; Wang, A; Wang, Q; Wang, X; Lavis, JN
Jan-2022COVID-19 rapid evidence profile #28: What is the filtration performance of KN95 masks compared to surgical and N95 masks, and how can their use be optimized in hospital settings?Al-Khateeb, S; Bain, T; Bhuiya, AR; Mansilla, C; Mehta, V; Sood, T; Wang, Q; Soueidan, S; Rintjema, J; Wang, A; Lavis, JN; Wilson, MG
Showing results 1 to 20 of 87  next >
Sherman Centre for Digital Scholarship     McMaster University Libraries
©2022 McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L8 | 905-525-9140 | Contact Us | Terms of Use & Privacy Policy | Feedback

Report Accessibility Issue